Does Pacira’s ioveradeg Pilot Data and Smart Tip Clearance Change The Bull Case For Pacira (PCRX)?

In early December 2025, Pacira BioSciences reported results from a randomized 30-patient pilot study comparing its ioveradeg cryoneurolysis system to radiofrequency ablation for chronic low back pain, ...
Zacks Investment Research on MSN

PCRX's Iovera Outperforms RFA Therapy in Pilot Study for Low Back Pain

Pacira BioSciences PCRX announced results from a pilot study evaluating the unique therapeutic approach of its iovera system ...
New Jersey Business Magazine

Managing Chronic Conditions

With chronic illnesses like cancer, heart disease, and diabetes on the rise – in fact, it is believed that some 60% of adults ...
The Manila Times

Pacira BioSciences Announces Results From 12-Month Pilot Study Demonstrating Favorable Safety and Significant Improvements in Pain With iovera° Compared to R…

The unblinded, single-center pilot study evaluated patients with facet-mediated CLBP who were randomized to receive either ...

Pacira BioSciences Announces Results From 12-Month Pilot Study Demonstrating Favorable Safety and Significant Improvements in Pain With iovera° Compared to R…

New data published in Pain Physician shows significant improvement in functional outcomes with iovera° ---- Fewer iovera° ...
American Association of Individual Investors

3 Undervalued Health Care Equipment & Supplies Stocks for Friday, December 05

Discover the top 3 undervalued Health Care Equipment & Supplies stocks for Friday, December 05 based on AAII’s Stock Grades.